<DOC>
	<DOCNO>NCT00470392</DOCNO>
	<brief_summary>The purpose study 1 ) determine whether Imiquimod Steroid pretreatment modifies UVB laser light response result increase cell death compare UVB laser light alone ; 2 ) determine pretreatment psoriatic lesion Imiquimod Steroid prior UVB laser light exposure selectively effect various T cell function ; 3 ) determine clinical result Imiquimod/Steroid/UVB laser light correlate change immuno-histochemical change skin ; 4 ) determine single high dose lesion limit UVB laser light intervention combine Imiquimod Steroid influence T cell change</brief_summary>
	<brief_title>Mechanistically-based Optimization UV Radiation Therapy Psoriasis</brief_title>
	<detailed_description>The characteristic lesion psoriasis sharply demarcate erythematous papule plaque excessive scaling due hyperproliferating keratinocytes , infiltrate granulocyte , dense mononuclear infiltrate activate T cell . To date , one mechanism explanatory panoply change occur dermis epidermis psoriasis patient . Several key finding show cutaneous T cell play key role propagation disease ; memory-type T cell home skin , specifically due expression cutaneous lymphocyte antigen ( CLA ) , main effector cell psoriatic tissue responsible production cytokine result exacerbate cutaneous inflammation . T cell recruitment think occur psoriasis , part , result cytokine chemokine release keratinocytes , macrophage , endothelial cell . CLA-positive T cell migrate tissue memory-effector T cell activate expand . This migration critical maintenance psoriasis lesion , anti-LFA-1 antibody ( efalizumab ) effective treat psoriasis , result blood lymphocytosis tissue depletion T cell . Despite many year use UVB phototherapy treatment psoriasis , mechanism action base mainly vitro exposure isolate cell extrapolation UV effect normal skin , little direct data lesional skin . Previously , study determine optimal single efficacious dose use Excimer laser , refine mechanism UVB action psoriasis , develop key cytokine quantitative meth -ods assess target mRNA level psoriatic tissue treatment , demonstrate regulatory T cell psoriasis tissue blood appear functional defect , demonstrate UVA component solar radiation critical significant contributor UV-induced vivo immuno-suppression . All previous finding lead u current hypothesis direct selective apoptotic effect T mem/Teff cell may result decreased APC activation IL-12 over-riding Treg suppression re-balanced Tre : Tmem/eff cell ratio turn may sustain remittive effect ( high duration multi-month clearing psoriasis lesion single UVB laser light treatment . )</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>The presence plaquetype psoriasis area trunk , buttock , extremity amenable biopsy evaluable disease least 2 cm target treatment site separate 1 cm Age 1880 , gender , ethnicities No contraindication phototherapy biopsy procedures No topical steroid , tar , phototherapy , Vitamin D , retinoid therapy target lesion least 1 week prior study No systemic psoriasis therapy least four week prior study Able give inform consent IRB approval procedure Photosensitivity disorder Active untreated disease medication usage may interfere UVB , wound healing , immune function Hypersensitivity local anesthetic Inability provide inform consent Pregnancy /or lactate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Erythema</keyword>
	<keyword>optimization</keyword>
	<keyword>Papule</keyword>
	<keyword>Plaque</keyword>
	<keyword>pretreatment</keyword>
	<keyword>T cell</keyword>
	<keyword>UVB laser light</keyword>
	<keyword>psoriasis</keyword>
	<keyword>topical administration</keyword>
</DOC>